Jacco van Rheenen

Oncode Institute Netherlands / Cancer Institute in Amsterdam / University Medical Center Utrecht

Jacco van Rheenen is senior group leader at the Oncode Institute and Netherlands Cancer Institute in Amsterdam and full professor at the University Medical Center Utrecht.

His group studies the identity, behavior, and fate of cells that drive the initiation and progression of cancer. These populations of cells are rare, and their behavior (e.g. migration) and traits (e.g. stemness) change over time. To study these dangerous cells, they have developed microscopy techniques to visualize individual cells in real-time in whole bodies. By these techniques, they revealed multiple important factors within the single cell heterogeneity that are crucial in the processes of tissue homeostasis, tumor initiation and tumor progression.

For his work he received multiple awards including the Stem Cells Young Investigator Award, the Dr. Josef Steiner Cancer Research Foundation Award, and the Ammodo Science Award.

Back to Virtual Conference Speakers

3D mammosphere culture of breast epithelial cell line MCF10A.

Courtesy of Dr. Emer Bourke, NUI Galway

Phospho-Akt expression and localisation

Mediated by VEGF in A549 lung cancer cells. Visualised by high content image analysis.

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

Metaphase chromosome spread of Jurkat T-lymphoma cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Apoptosis assessment of SKMES-1 lung cancer cells

Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

HeLa Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

IACR & EACR Joint Conference 2020

26 — 28 February 2020 at Galway Bay Hotel, Galway

Find Out More

Mitotic Chronic Myelogenous Leukaemia K562 Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Cell to Cell Tweeting

Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC)

Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.

Confocal Microscopy Analysis

Of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

IACR 2023 Carer’s Bursary €300

Apply for funding towards the additional costs of care while attending conference. Five Bursaries Available.

Find Out More

Registration/ Membership for IACR 2023

Registration for the 59th Annual Conference in the Radisson Blu hotel, Athlone is Now Open.

EACR Membership is Included

The IACR is an affiliated national society and its members benefit from full membership of the EACR.

See EACR Benefits

Late Breaking Abstracts in Now OPEN!

Submit An Abstract

Biomedical Session Abstracts

Deadline: Midnight, Friday, 20th January 2023

Please note:
- Patrick Johnston Lay submission category is now closed
- Late Breaking Abstracts submitted to the Biomedical Sessions will be considered for Display Poster Presentation.

Social Nursing and Allied Health (SNAH) Abstracts

Deadline: Midnight, Monday, 9th January 2023

SNAH abstract submissions will remain open until Monday 9th January.

Any questions?
Please contact Sinead on: sinead@sineadcassidy.com

Donate to IACR

Contact Us

Contact Us
Irish Association for Cancer Research
9A Coolkill, Sandyford, Dublin 18

T: +353 (0)1 295 8859
E: info@iacr.ie

Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations.

Registered Charity Number (RCN): 20030117